Wang Shiqi
Drug Research Program, Division of Pharmaceutical Chemistry and Technology, Faculty of Pharmacy, University of Helsinki, Helsinki, Finland.
Front Chem. 2021 Mar 23;9:645297. doi: 10.3389/fchem.2021.645297. eCollection 2021.
The intracellular delivery of emerging biomacromolecular therapeutics, such as genes, peptides, and proteins, remains a great challenge. Unlike small hydrophobic drugs, these biotherapeutics are impermeable to the cell membrane, thus relying on the endocytic pathways for cell entry. After endocytosis, they are entrapped in the endosomes and finally degraded in lysosomes. To overcome these barriers, many carriers have been developed to facilitate the endosomal escape of these biomacromolecules. This mini-review focuses on the development of anionic pH-responsive amphiphilic carboxylate polymers for endosomal escape applications, including the design and synthesis of these polymers, the mechanistic insights of their endosomal escape capability, the challenges in the field, and future opportunities.
新兴生物大分子疗法(如基因、肽和蛋白质)的细胞内递送仍然是一个巨大的挑战。与小的疏水性药物不同,这些生物疗法不能透过细胞膜,因此依赖内吞途径进入细胞。内吞后,它们被困在内体中,最终在溶酶体中降解。为了克服这些障碍,人们开发了许多载体来促进这些生物大分子从内体中逃逸。本综述聚焦于用于内体逃逸应用的阴离子pH响应性两亲羧酸聚合物的发展,包括这些聚合物的设计与合成、其内体逃逸能力的机理见解、该领域的挑战以及未来机遇。